Elsevier

Gynecologic Oncology

Volume 135, Issue 3, December 2014, Pages 409-410
Gynecologic Oncology

Editorial
AKT1 gene amplification as a biomarker of treatment response in ovarian cancer: Mounting evidence of a therapeutic target

https://doi.org/10.1016/j.ygyno.2014.11.007Get rights and content

References (10)

  • E. Despierre et al.

    The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment

    Gynecol Oncol

    (2010)
  • T.I. Zack et al.

    Pan-cancer patterns of somatic copy number alteration

    (2013)
  • The Cancer Genome Atlas Network

    Integrated genomic analyses of ovarian carcinoma

    Nature

    (2011)
  • B.E. Cristiano et al.

    A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition

    Cancer Res

    (2006)
  • E.A. Stronach et al.

    DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance

    Neoplasia

    (2011)
There are more references available in the full text version of this article.

Cited by (0)

View full text